Empowered Funds
RCKT icon

Empowered Funds’s Rocket Pharmaceuticals RCKT Stock Holding History

Empowered Funds’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$338K Buy
+128,683
New +$446K ﹤0.01% 1983

Other funds holding RCKT

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Empowered Funds's RCKT Position: Q3 2026 in Review

Empowered Funds opened a new position in Rocket Pharmaceuticals (RCKT) in Q3 2026: 128,683 shares worth $338K. The stake represents ﹤0.01% of the portfolio and ranks #1983 among its holdings.

116 funds tracked by Wall St. Rank hold RCKT as of Q3 2026.

  • Empowered Funds held 128,683 shares of Rocket Pharmaceuticals worth $338K as of Q3 2026.
  • Rocket Pharmaceuticals was a new Empowered Funds position in Q3 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #1983 holding.
  • 116 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.